Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?
- PMID: 37823054
- PMCID: PMC10562641
- DOI: 10.3389/fonc.2023.1278402
Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?
Abstract
Recently published work provide the first known evidence of a malignancy-associated regulatory mechanism, functionally connecting a phospho-regulated degron domain embedded in a receptor tyrosine kinase (RTK), with its ectopic expression in cancer, conditional to a specific autocrine growth factor signal. Mechanistically, the growth factor-triggered phosphorylation inhibits the degron domain present in the regulated RTK, blocking access to a specific degradation complex. This ultimately rescues the RTK from rapid ubiquitin-proteasome-system-mediated degradation and, most importantly, causes its cellular overexpression. This mechanism, which has been here assigned the new functional name "Over-Expression by Degradation Rescue" (OEDR), provides an additional layer and potentially preferential tool for the control of RTKs expression in cancer, in addition to other mechanisms acting at the transcriptional and messenger transcript stabilization levels. We propose this newly defined phosphorylation/ubiquitination switch-dependent signal to bear wider unexploited relevance in cell biology and human pathophysiology. The recently identified mechanism underlying an OEDR-regulated RTK is discussed herein in the context of physiological endocrine circuits and cancer.
Keywords: RTK; UPS; UbE3L; degron; gf; pDegron; paDegron; piDegron.
Copyright © 2023 Scalia and Williams.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
A Post-translational Modification-enhanced Pull-down Method to Study Degron Domains and the Associated Protein Degradation Complexes.Bio Protoc. 2023 Sep 20;13(18):e4816. doi: 10.21769/BioProtoc.4816. eCollection 2023 Sep 20. Bio Protoc. 2023. PMID: 37753472 Free PMC article.
-
Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.J Hepatol. 2019 Mar;70(3):470-482. doi: 10.1016/j.jhep.2018.11.027. Epub 2018 Dec 6. J Hepatol. 2019. PMID: 30529386
-
Endocytosis of receptor tyrosine kinases.Cold Spring Harb Perspect Biol. 2013 May 1;5(5):a017459. doi: 10.1101/cshperspect.a017459. Cold Spring Harb Perspect Biol. 2013. PMID: 23637288 Free PMC article. Review.
-
All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.Int J Mol Sci. 2021 Jun 14;22(12):6342. doi: 10.3390/ijms22126342. Int J Mol Sci. 2021. PMID: 34198477 Free PMC article. Review.
-
Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.Front Endocrinol (Lausanne). 2022 Jul 28;13:971162. doi: 10.3389/fendo.2022.971162. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35966060 Free PMC article. Review.
Cited by
-
Autocrine IGF-II-Associated Cancers: From a Rare Paraneoplastic Event to a Hallmark in Malignancy.Biomedicines. 2023 Dec 22;12(1):40. doi: 10.3390/biomedicines12010040. Biomedicines. 2023. PMID: 38255147 Free PMC article.
References
-
- Gardner DG, Shoback DM, Greenspan FS. Greenspan’s Basic & Clinical Endocrinology. 10th ed. New York, N.Y: McGraw-Hill Education LLC; (2017).
LinkOut - more resources
Full Text Sources